179 related articles for article (PubMed ID: 28557310)
1. Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.
Bahig H; Nguyen-Tan PF; Filion É; Roberge D; Thanomsack P; de Guise J; Blais D; Doucet R; Létourneau-Guillon L; Lambert L
J Med Imaging Radiat Oncol; 2017 Oct; 61(5):666-673. PubMed ID: 28557310
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.
Zhang Y; Chiu T; Dubas J; Tian Z; Lee P; Gu X; Yan Y; Sher D; Timmerman R; Zhao B
Radiat Oncol; 2019 Nov; 14(1):193. PubMed ID: 31684993
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
4. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
5. 4D VMAT planning and verification technique for dynamic tracking using a direct aperture deformation (DAD) method.
Zhang Y; Yang Y; Fu W; Li X; Li T; Heron DE; Huq MS
J Appl Clin Med Phys; 2017 Mar; 18(2):50-61. PubMed ID: 28300367
[TBL] [Abstract][Full Text] [Related]
6. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
7. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
Chin E; Loewen SK; Nichol A; Otto K
Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
[TBL] [Abstract][Full Text] [Related]
8. Investigation of a novel algorithm for true 4D-VMAT planning with comparison to tracked, gated and static delivery.
Chin E; Otto K
Med Phys; 2011 May; 38(5):2698-707. PubMed ID: 21776806
[TBL] [Abstract][Full Text] [Related]
9. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of free-breathing versus respiratory motion-managed radiotherapy via four-dimensional computed tomography-based volumetric-modulated arctherapy for lung cancer.
Sarihan S; Tunc SG; Kahraman A; Irem ZK
Cancer Radiother; 2023 Dec; 27(8):698-704. PubMed ID: 37925346
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early-stage glottic cancer.
Matthiesen C; Herman Tde L; Singh H; Mascia A; Confer M; Simpson H; Higby C; Arain A; Keole S; Herman T; Bogardus C; Zhao YD; Ahmad S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):221-8. PubMed ID: 25146003
[TBL] [Abstract][Full Text] [Related]
12. Clinical and dosimetric implications of intensity-modulated radiotherapy for early-stage glottic carcinoma.
Ward MC; Pham YD; Kotecha R; Zakem SJ; Murray E; Greskovich JF
Med Dosim; 2016; 41(1):64-9. PubMed ID: 26553472
[TBL] [Abstract][Full Text] [Related]
13. Organ motion in linac-based SBRT for glottic cancer.
Perillo A; Landoni V; Farneti A; Sanguineti G
Radiat Oncol; 2021 Jun; 16(1):106. PubMed ID: 34118965
[TBL] [Abstract][Full Text] [Related]
14. Functional image-guided radiotherapy planning in respiratory-gated intensity-modulated radiotherapy for lung cancer patients with chronic obstructive pulmonary disease.
Kimura T; Nishibuchi I; Murakami Y; Kenjo M; Kaneyasu Y; Nagata Y
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e663-70. PubMed ID: 22245191
[TBL] [Abstract][Full Text] [Related]
15. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
16. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
Yamamoto T; Kabus S; von Berg J; Lorenz C; Keall PJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):279-88. PubMed ID: 20646852
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy.
Chung H; Jung J; Jeong C; Kwak J; Park JH; Kim SS; Yoon SM; Song SY; Kim JH; Choi EK; Cho S; Cho B
PLoS One; 2018; 13(9):e0202765. PubMed ID: 30192793
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
20. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis.
McGrath SD; Matuszak MM; Yan D; Kestin LL; Martinez AA; Grills IS
Radiother Oncol; 2010 May; 95(2):153-7. PubMed ID: 20116115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
